YDES
YD Bio Limited Ordinary Shares NASDAQ Listed Aug 29, 2025$7.64
+2.96%
vs $7.42
Mkt Cap $541.2M
52w Low $1.70
29.3% of range
52w High $22.00
50d MA $3.60
200d MA $6.18
P/E (TTM)
—
EV/EBITDA
—
P/B
4.8x
Debt/Equity
0.0x
ROE
—
P/FCF
-6.5x
RSI (14)
75.60
ATR (14)
$0.91
Beta
0.22
50d MA
$3.60
200d MA
$6.18
Avg Volume
509.6K
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
No. 3, Xingnan St. · Taipei, TX 115001 · TW
Data updated apr 24, 2026 11:46am
· Source: financialmodelingprep.com